Is a COVID-19 vaccine developed by nature already at work?
Copyright © 2020 Elsevier Ltd. All rights reserved..
The COVID-19 positive cases are increasing at an alarming rate across the world. On the contrary, the morbidity and mortality are showing decreasing trend as time progresses. The most intriguing part is the rise in asymptomatic Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) positive cases in the population, which made us speculate some kind of gradual development of immunity in the population. To date, no attention has been given to the accumulation of killed/inactivated/degenerated SARS-CoV-2 associated molecular particle patterns (SAMPPs). In this paper, we introduced the concept of SAMMPs and its existence on inanimate objects is quite conceivable due to the size of SARS-CoV-2 and exuberant shedding of the virus in respiratory secretions. SAMPPs can come into the contact with mucosal surfaces and thereof associated antigen-presenting dendritic cells. Thus, we hypothesized the existence of SAMPPs mediated the development of immunity against SARS-CoV-2 infection, which has caused an increase in the incidence rate of asymptomatic cases and a decrease in mortality rate. To understand the existence of SAMPPs associated natural immunity against SARS-CoV-2, future population based serological testing are recommended to investigate serum antibody levels against various molecular particles associated with SAMPPs.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:145 |
---|---|
Enthalten in: |
Medical hypotheses - 145(2020) vom: 15. Dez., Seite 110335 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sharma, Nilesh Kumar [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antiviral Agents |
---|
Anmerkungen: |
Date Completed 04.01.2021 Date Revised 29.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.mehy.2020.110335 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316287636 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM316287636 | ||
003 | DE-627 | ||
005 | 20240329235748.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.mehy.2020.110335 |2 doi | |
028 | 5 | 2 | |a pubmed24n1355.xml |
035 | |a (DE-627)NLM316287636 | ||
035 | |a (NLM)33059225 | ||
035 | |a (PII)S0306-9877(20)32636-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sharma, Nilesh Kumar |e verfasserin |4 aut | |
245 | 1 | 0 | |a Is a COVID-19 vaccine developed by nature already at work? |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.01.2021 | ||
500 | |a Date Revised 29.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier Ltd. All rights reserved. | ||
520 | |a The COVID-19 positive cases are increasing at an alarming rate across the world. On the contrary, the morbidity and mortality are showing decreasing trend as time progresses. The most intriguing part is the rise in asymptomatic Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) positive cases in the population, which made us speculate some kind of gradual development of immunity in the population. To date, no attention has been given to the accumulation of killed/inactivated/degenerated SARS-CoV-2 associated molecular particle patterns (SAMPPs). In this paper, we introduced the concept of SAMMPs and its existence on inanimate objects is quite conceivable due to the size of SARS-CoV-2 and exuberant shedding of the virus in respiratory secretions. SAMPPs can come into the contact with mucosal surfaces and thereof associated antigen-presenting dendritic cells. Thus, we hypothesized the existence of SAMPPs mediated the development of immunity against SARS-CoV-2 infection, which has caused an increase in the incidence rate of asymptomatic cases and a decrease in mortality rate. To understand the existence of SAMPPs associated natural immunity against SARS-CoV-2, future population based serological testing are recommended to investigate serum antibody levels against various molecular particles associated with SAMPPs | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Coronavirus | |
650 | 4 | |a Immunity | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a Vaccine | |
650 | 7 | |a Antiviral Agents |2 NLM | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
650 | 7 | |a Pathogen-Associated Molecular Pattern Molecules |2 NLM | |
650 | 7 | |a Vaccines, DNA |2 NLM | |
700 | 1 | |a Sarode, Sachin C |e verfasserin |4 aut | |
700 | 1 | |a Sarode, Gargi |e verfasserin |4 aut | |
700 | 1 | |a Patil, Shankargouda |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medical hypotheses |d 1978 |g 145(2020) vom: 15. Dez., Seite 110335 |w (DE-627)NLM00007487X |x 1532-2777 |7 nnns |
773 | 1 | 8 | |g volume:145 |g year:2020 |g day:15 |g month:12 |g pages:110335 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mehy.2020.110335 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 145 |j 2020 |b 15 |c 12 |h 110335 |